“There is growing interest in using and learning about Ayurvedic
remedies on a global scale. Ayurvedic products from our natural
heritage need to be integrated into national and international
healthcare programmes with proficiency in the global healthcare market
in order to fully realise its potential for bringing out the therapeutic
approaches available in the oldest system of medicine. Similar to
pharmaceutical items, Ayurvedic products require standardisation and
evaluation using trustworthy evaluatory techniques from contemporary
sciences. Prior to developing pre-clinical and clinical investigations, a
thorough literature assessment based on systematic capture from many
sources is absolutely necessary. To produce a quality product,
authenticated and standardised raw materials must be used.
Standardisation of phytochemicals and creation of qualitative criteria.
For the assurance of the quality of single or polyherbal formulations,
phytochemical standardisation and the establishment of qualitative
parameters with the various analytical techniques are equally crucial.
Ayurvedic, Siddha, and Unani official formularies and regulatory
compendiums are published and updated by the Pharmacopoeia
Commission. For the purpose of guaranteeing the quality standards of
Ayurvedic raw materials and pharmaceuticals, these published
requirements were incorporated into Drug and Cosmetics Act 1940 and
Rules 1945 and were applied universally throughout India. But in order
for Ayurvedic medications to be accepted on a global basis, they must
adhere to the “One Earth, One Herb, One Standard” and be listed in the
“International Pharmacopoeia”.